Heranba Industries Ltd (NSE: HERANBA, BSE: 543266) is a Mumbai, Maharashtra-based company in the Crop Protection Chemicals industry. With a market capitalisation of ₹657 Cr, it ranks #1,836 by market cap among the 6,137 Indian listed companies on FinBizNet, and #23 of 45 in Crop Protection Chemicals. At ₹147.26 (as of 25 Oct 2026), the share price is 53.3% below its 52-week high of ₹315.00 and 1.6% above its 52-week low of ₹145.00. The share price is down 51.7% over one year and down 15.8% over three months.
| Current Price | ₹147.26 |
|---|---|
| Market Cap | ₹657 Cr |
| NSE Symbol | HERANBA |
| BSE Code | 543266 |
| Sector | Materials > Chemicals > Fertilizers & Agri Chemicals |
| Sub-Industry | Fertilizers and Agricultural Chemicals > Crop Protection Chemicals |
| P/E Ratio | -8.4 |
| Return on Equity | -9.58% |
| Return on Assets | -0.50% |
| 52-Week Range | ₹145.00 – ₹315.00 |
| 1-Year Price Change | -51.7% |
| 3-Month Price Change | -15.8% |
| Beta (1Y) | 0.53 |
| Dividend Yield | 0.00% |
| Headquarters | Mumbai, Maharashtra |
| Website | www.heranba.co.in |
| Revenue | ₹383 Cr |
|---|---|
| Net Profit | ₹7 Cr |
| Net Margin | 1.8% |
| EPS (Basic) | ₹1.78 |
| Basis | consolidated |
Figures in ₹ crore, parsed from the company's exchange filing (XBRL).
Heranba Industries Limited manufactures and sells various agrochemicals in India and internationally. It offers intermediates, such as cypermethric acid chloride (CMAC), high CIS CMA and CMAC, high trans CMA and CMAC, bromobenzenes, metaphenoxy benzaldehyde and benzyl alcohol, and NPBR; and insecticides, including cypermethrin, deltamethrin, alpha cypermethrin, tolfenpyrad, lambda cyhalothrin, permethrin, profenophos, dinotefuran, temephos, theta cypermethrin, diflubenzuron, ethion, methamidophos, thiophanate-methyl, and bifenthrin. The company also provides fungicides comprising tricyclazole, hexaconazole, tebuconazole, thifluzamide, propiconazole, picoxystrobin, and dodine; herbicides consisting of bispyribac sodium, clodinafop, tembotorine, and pendimethalin; and plant growth regulators. In addition, it offers formulations, such as emulsifiable concentrate, capsule suspension, suspension concentrate, oil dispersion, concentrated aqueous emulsions, wettable powder, suspoemulsion, wat
1. Manufacture and Sale of Agro Chemical Business-This segment manufactures intermediates, formulations, and technical products for farmers and pest control companies.
1. Manufacture and Sale of Agro Chemical Business-100%
| Company | Market Cap | P/E | ROE | Latest Qtr Revenue | 1Y Change |
|---|---|---|---|---|---|
| United Phosphorus Ltd. (UPL) | ₹45,036 Cr | 23.7 | 5.61% | ₹10,181 Cr | -25.2% |
| PI Industries Ltd | ₹33,205 Cr | 24.8 | 12.35% | ₹1,702 Cr | -42.2% |
| Sumitomo Chemicals India Ltd | ₹20,203 Cr | 36 | 17.24% | ₹1,063 Cr | -30.3% |
| Bayer Cropscience Ltd | ₹16,360 Cr | 23.2 | 23.70% | ₹1,835 Cr | -33.8% |
| Eid Parry India Ltd | ₹12,315 Cr | 21.1 | 9.91% | ₹9,018 Cr | -39.2% |
| Sharda Cropchem Ltd | ₹6,544 Cr | 9.2 | 24.16% | ₹1,074 Cr | -22.0% |
| Rallis India Ltd. | ₹3,985 Cr | 21.6 | 9.32% | ₹858 Cr | -31.6% |
| Dhanuka Agritech Ltd | ₹3,867 Cr | 13.6 | 18.62% | ₹462 Cr | -40.1% |
| Heranba Industries Ltd | ₹657 Cr | -8.4 | -9.58% | ₹383 Cr | -51.7% |
Listed by market capitalisation. Ratios are shown for context only.
Heranba Industries Ltd is trading at ₹147.26, with a market capitalisation of ₹657 Cr.
Heranba Industries Ltd operates in the Materials > Chemicals > Fertilizers & Agri Chemicals space (Fertilizers and Agricultural Chemicals > Crop Protection Chemicals).
Heranba Industries Ltd has a P/E of -8.4 and a return on equity of -9.58%.
Heranba Industries Ltd is listed on the NSE under the symbol HERANBA and on the BSE under the scrip code 543266.
Heranba Industries Ltd's share price is down 51.7% over one year and down 15.8% over three months. Its 52-week range is ₹145.00 to ₹315.00.
In Q1 FY27, Heranba Industries Ltd reported revenue of ₹383 Cr and net profit of ₹7 Cr, with basic EPS of ₹1.78 (consolidated, parsed from the company's exchange filing).
Data as of 25 Oct 2026. Descriptive market data only — not investment advice.